| Value | ₹1,557 Cr |
|---|
BSE filing, NSE: MANGALAM. Summary written from the filing by ALFA Finder's alert engine.
Mangalam Drugs and Organics Ltd: key numbers
- Share price
- ₹29.10
- Market cap
- ₹46.06 Cr
- Revenue (annual)
- ₹232.1 Cr
- Net profit (annual)
- ₹-44.40 Cr
- P/E (TTM)
- -1.2×Sector 46.1×
- Promoter holding
- 35.65%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mangalam Drugs and Organics Ltd
All →Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs issued a postal ballot notice seeking approval to re-appoint Praveen Saxena as independent director for a second five-year term. Voting closes 17 June 2026.
Mangalam Drugs and Organics Debt & Borrowing: ₹15.57 Cr
Mangalam Drugs and Organics Limited reported defaults on bank loan obligations totaling Rs. 15.57 Crore. The defaults involve cash credit accounts at Bank of Maharashtra and Bank of Baroda.
- Value
- ₹15.57 Cr
Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs and Organics Limited has issued a Postal Ballot notice to seek shareholder approval for appointing Shri Prabhakar Raghunath Zavar as an Independent Director. The appointment is for five years.
Mangalam Drugs and Organics Other Announcement
Mangalam Drugs and Organics Limited announced the appointment of new Statutory and Secretarial Auditors following the tenure completion of the previous Statutory Auditor.
Mangalam Drugs and Organics Management Change
Manglam Drugs and Organics Ltd. has appointed M/s S.N. Nanda & Co. as Statutory Auditor and M/s L.N. Joshi & Co. as Secretarial Auditor.
Mangalam Drugs and Organics Annual General Meeting
Mangalam Drugs and Organics Ltd held its 53rd Annual General Meeting on September 23, 2026. The meeting transacted standard business items including financial statement adoption and auditor appointments.
Other debt & borrowing announcements
All →Electrotherm (India) Debt & Borrowing: ₹59.81 Cr
Electrotherm disclosed a Rs 59.81 Crore default on bank loans as at 30 September 2026. The loans were assigned to an ARC under a settlement.
- Value
- ₹59.81 Cr
Shree Renuka Sugars Debt & Borrowing: ₹1.55 Cr
Shree Renuka Sugars paid monthly interest on four listed NCD series on October 29, 2026. Total interest paid across the series is Rs. 1.58 Crore.
- Value
- ₹1.55 Cr
Avenue Supermarts Debt & Borrowing: ₹200 Cr
Avenue Supermarts allotted Rs 200 crore of unsecured commercial paper on 29 October 2026, maturing 11 December 2026 at 7.20% coupon. The paper carries an ICRA A1+ rating and is proposed to be listed on BSE.
- Value
- ₹200.0 Cr
- Execution
- 43 days
Aye Finance Debt & Borrowing: ₹1.76 Cr
Aye Finance paid Rs.1.76 Crore monthly interest on its 9.75% secured NCDs on the due date, with no delay. Payment was made on time, matching the scheduled amount.
- Value
- ₹1.76 Cr
IndusInd Bank Debt & Borrowing: ₹227.1 Cr
IndusInd Bank certified payment of Rs.227.08 crore interest on its Tier 2 Bonds (ISIN INE095A08090) on the due date of 29 October 2026. This is a Regulation 57 debt servicing confirmation.
- Value
- ₹227.1 Cr
IFCI Debt & Borrowing: ₹24.95 Cr
IFCI paid Rs.24.95 Crore annual interest on its 9.98% Series-55 unsecured bonds on October 29, 2026. Payment was made on the due date with no delay.
- Value
- ₹24.95 Cr